Do analysts recommend QTI or TLSI?

TriSalus Life Sciences has a consensus target price of $7.50, indicating a potential upside of 72.61%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, analysts clearly believe TriSalus Life Sciences is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 TriSalus Life Sciences 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Do analysts prefer SMTI or QTI?

Sanara MedTech presently has a consensus price target of $34.00, indicating a potential upside of 57.76%. Given Sanara MedTech's stronger consensus rating and higher possible upside, equities analysts clearly believe Sanara MedTech is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is SMTI or QTI more profitable?

Sanara MedTech has a net margin of -31.23% compared to QT Imaging's net margin of -58.93%. Sanara MedTech's return on equity of -3.19% beat QT Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Sanara MedTech -31.23% -3.19% -0.56% QT Imaging -58.93% -4,220.38% -51.77%

Do analysts prefer EMBC or QTI?

Embecta presently has a consensus target price of $11.00, indicating a potential upside of 256.56%. Given Embecta's higher probable upside, equities research analysts clearly believe Embecta is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Embecta 3 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.40 QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings and valuation, EMBC or QTI?

Embecta has higher revenue and earnings than QT Imaging. QT Imaging is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Embecta $1.04B 0.18 $95.40M $1.90 1.62 QT Imaging $18.92M 2.53 -$21.08M -$1.24 N/A

Is EMBC or QTI more profitable?

Embecta has a net margin of 10.73% compared to QT Imaging's net margin of -58.93%. Embecta's return on equity of -23.96% beat QT Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Embecta 10.73% -23.96% 14.12% QT Imaging -58.93% -4,220.38% -51.77%

Do analysts rate QTI or KRMD?

KORU Medical Systems has a consensus price target of $7.25, indicating a potential upside of 83.31%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, analysts plainly believe KORU Medical Systems is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 KORU Medical Systems 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60

Do analysts prefer QTI or INFU?

InfuSystem has a consensus price target of $15.00, indicating a potential upside of 67.97%. Given InfuSystem's stronger consensus rating and higher probable upside, analysts clearly believe InfuSystem is more favorable than QT Imaging. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QT Imaging 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 InfuSystem 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67

Which has preferable valuation and earnings, QTI or INFU?

InfuSystem has higher revenue and earnings than QT Imaging. QT Imaging is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio QT Imaging $18.92M 2.53 -$21.08M -$1.24 N/A InfuSystem $142.40M 1.27 $870K $0.38 23.50

Is QTI or INFU more profitable?

InfuSystem has a net margin of 1.12% compared to QT Imaging's net margin of -58.93%. InfuSystem's return on equity of 2.78% beat QT Imaging's return on equity. Company Net Margins Return on Equity Return on Assets QT Imaging -58.93% -4,220.38% -51.77% InfuSystem 1.12% 2.78% 1.41%

QT Imaging (QTI) Competitors

$3.97 -0.07 (-1.73%)

As of 01:14 PM Eastern

Compare

QTI vs. TLSI, SMTI, EMBC, KRMD, and INFU

Should you buy QT Imaging stock or one of its competitors? MarketBeat compares QT Imaging with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with QT Imaging include TriSalus Life Sciences (TLSI), Sanara MedTech (SMTI), Embecta (EMBC), KORU Medical Systems (KRMD), and InfuSystem (INFU). These companies are all part of the "medical equipment" industry.

How does QT Imaging compare to TriSalus Life Sciences?

QT Imaging (NASDAQ:QTI) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation.

TriSalus Life Sciences has a consensus target price of $7.50, indicating a potential upside of 72.61%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, analysts clearly believe TriSalus Life Sciences is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
TriSalus Life Sciences	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

24.2% of QT Imaging shares are held by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are held by institutional investors. 28.8% of QT Imaging shares are held by company insiders. Comparatively, 16.3% of TriSalus Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

QT Imaging has higher earnings, but lower revenue than TriSalus Life Sciences. QT Imaging is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$18.92M	2.53	-$21.08M	-$1.24	N/A
TriSalus Life Sciences	$44.88M	5.95	-$39.23M	-$1.41	N/A

In the previous week, TriSalus Life Sciences had 5 more articles in the media than QT Imaging. MarketBeat recorded 7 mentions for TriSalus Life Sciences and 2 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.46 beat TriSalus Life Sciences' score of 0.21 indicating that QT Imaging is being referred to more favorably in the media.

Company	Overall Sentiment
QT Imaging	Positive
TriSalus Life Sciences	Neutral

QT Imaging has a beta of -0.07, suggesting that its share price is 107% less volatile than the broader market. Comparatively, TriSalus Life Sciences has a beta of 0.48, suggesting that its share price is 52% less volatile than the broader market.

QT Imaging has a net margin of -58.93% compared to TriSalus Life Sciences' net margin of -60.85%. TriSalus Life Sciences' return on equity of 0.00% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QT Imaging	-58.93%	-4,220.38%	-51.77%
TriSalus Life Sciences	-60.85%	N/A	-69.91%

Summary

TriSalus Life Sciences beats QT Imaging on 9 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Sanara MedTech?

Sanara MedTech (NASDAQ:SMTI) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment.

Sanara MedTech has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, QT Imaging has a beta of -0.07, meaning that its stock price is 107% less volatile than the broader market.

Sanara MedTech has a net margin of -31.23% compared to QT Imaging's net margin of -58.93%. Sanara MedTech's return on equity of -3.19% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanara MedTech	-31.23%	-3.19%	-0.56%
QT Imaging	-58.93%	-4,220.38%	-51.77%

Sanara MedTech presently has a consensus price target of $34.00, indicating a potential upside of 57.76%. Given Sanara MedTech's stronger consensus rating and higher possible upside, equities analysts clearly believe Sanara MedTech is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanara MedTech	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

QT Imaging has lower revenue, but higher earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanara MedTech	$103.12M	1.91	-$37.56M	-$3.77	N/A
QT Imaging	$18.92M	2.53	-$21.08M	-$1.24	N/A

In the previous week, Sanara MedTech had 2 more articles in the media than QT Imaging. MarketBeat recorded 4 mentions for Sanara MedTech and 2 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.46 beat Sanara MedTech's score of 1.19 indicating that QT Imaging is being referred to more favorably in the news media.

Company	Overall Sentiment
Sanara MedTech	Positive
QT Imaging	Positive

8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 42.0% of Sanara MedTech shares are held by company insiders. Comparatively, 28.8% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Sanara MedTech beats QT Imaging on 10 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Embecta?

Embecta (NASDAQ:EMBC) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

Embecta has higher revenue and earnings than QT Imaging. QT Imaging is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Embecta	$1.04B	0.18	$95.40M	$1.90	1.62
QT Imaging	$18.92M	2.53	-$21.08M	-$1.24	N/A

In the previous week, Embecta and Embecta both had 2 articles in the media. Embecta's average media sentiment score of 1.47 beat QT Imaging's score of 1.46 indicating that Embecta is being referred to more favorably in the media.

Company	Overall Sentiment
Embecta	Positive
QT Imaging	Positive

Embecta has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, QT Imaging has a beta of -0.07, suggesting that its share price is 107% less volatile than the broader market.

Embecta presently has a consensus target price of $11.00, indicating a potential upside of 256.56%. Given Embecta's higher probable upside, equities research analysts clearly believe Embecta is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Embecta	3 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.40
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

93.8% of Embecta shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 1.3% of Embecta shares are held by insiders. Comparatively, 28.8% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Embecta has a net margin of 10.73% compared to QT Imaging's net margin of -58.93%. Embecta's return on equity of -23.96% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Embecta	10.73%	-23.96%	14.12%
QT Imaging	-58.93%	-4,220.38%	-51.77%

Summary

Embecta beats QT Imaging on 11 of the 15 factors compared between the two stocks.

How does QT Imaging compare to KORU Medical Systems?

QT Imaging (NASDAQ:QTI) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.

In the previous week, QT Imaging had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 2 mentions for QT Imaging and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.89 beat QT Imaging's score of 1.46 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
QT Imaging	Positive
KORU Medical Systems	Very Positive

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 28.8% of QT Imaging shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

QT Imaging has a beta of -0.07, indicating that its stock price is 107% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, indicating that its stock price is 57% less volatile than the broader market.

KORU Medical Systems has a net margin of -5.27% compared to QT Imaging's net margin of -58.93%. KORU Medical Systems' return on equity of -13.61% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QT Imaging	-58.93%	-4,220.38%	-51.77%
KORU Medical Systems	-5.27%	-13.61%	-8.33%

KORU Medical Systems has higher revenue and earnings than QT Imaging. KORU Medical Systems is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$18.92M	2.53	-$21.08M	-$1.24	N/A
KORU Medical Systems	$41.13M	4.42	-$2.64M	-$0.05	N/A

KORU Medical Systems has a consensus price target of $7.25, indicating a potential upside of 83.31%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, analysts plainly believe KORU Medical Systems is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

KORU Medical Systems beats QT Imaging on 13 of the 16 factors compared between the two stocks.

How does QT Imaging compare to InfuSystem?

QT Imaging (NASDAQ:QTI) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

InfuSystem has a net margin of 1.12% compared to QT Imaging's net margin of -58.93%. InfuSystem's return on equity of 2.78% beat QT Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QT Imaging	-58.93%	-4,220.38%	-51.77%
InfuSystem	1.12%	2.78%	1.41%

InfuSystem has higher revenue and earnings than QT Imaging. QT Imaging is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$18.92M	2.53	-$21.08M	-$1.24	N/A
InfuSystem	$142.40M	1.27	$870K	$0.38	23.50

InfuSystem has a consensus price target of $15.00, indicating a potential upside of 67.97%. Given InfuSystem's stronger consensus rating and higher probable upside, analysts clearly believe InfuSystem is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
InfuSystem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

In the previous week, QT Imaging had 1 more articles in the media than InfuSystem. MarketBeat recorded 2 mentions for QT Imaging and 1 mentions for InfuSystem. QT Imaging's average media sentiment score of 1.46 beat InfuSystem's score of 0.50 indicating that QT Imaging is being referred to more favorably in the media.

Company	Overall Sentiment
QT Imaging	Positive
InfuSystem	Positive

QT Imaging has a beta of -0.07, suggesting that its stock price is 107% less volatile than the broader market. Comparatively, InfuSystem has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 71.1% of InfuSystem shares are owned by institutional investors. 28.8% of QT Imaging shares are owned by insiders. Comparatively, 10.8% of InfuSystem shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

InfuSystem beats QT Imaging on 12 of the 16 factors compared between the two stocks.

Get QT Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QTI vs. The Competition

Export

Metric	QT Imaging	Electromedical equipment Industry	Medical Sector	NASDAQ Exchange
Market Cap	$47.92M	$70.96M	$6.50B	$12.36B
Dividend Yield	N/A	N/A	2.67%	5.67%
P/E Ratio	-3.21	8.34	23.99	24.69
Price / Sales	2.53	194.03	538.03	166.93
Price / Cash	N/A	41.36	27.48	37.92
Price / Book	7.35	5.03	10.47	6.82
Net Income	-$21.08M	-$5.50M	$3.56B	$337.45M
7 Day Performance	4.47%	3.06%	1.21%	2.49%
1 Month Performance	-27.16%	-12.13%	2.14%	4.37%
1 Year Performance	378.89%	223.32%	26.24%	32.80%

QT Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QTI QT Imaging	1.4654 of 5 stars	$3.97 -1.7%	N/A	+387.3%	$47.92M	$18.92M	N/A	N/A	Positive News Short Interest Decrease Gap Up
TLSI TriSalus Life Sciences	3.5168 of 5 stars	$3.30 +3.8%	$7.50 +127.3%	-27.4%	$202.69M	$45.15M	N/A	106	Gap Up
SMTI Sanara MedTech	2.1339 of 5 stars	$22.12 +5.5%	$34.00 +53.7%	-27.8%	$202.62M	$103.12M	N/A	60
EMBC Embecta	4.3569 of 5 stars	$3.42 +2.9%	$11.00 +222.1%	-67.6%	$202.61M	$1.08B	1.80	1,850	Positive News
KRMD KORU Medical Systems	3.9693 of 5 stars	$4.14 +5.6%	$7.25 +75.1%	+23.8%	$190.15M	$41.13M	N/A	80	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QTI) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

QT Imaging (QTI) Competitors

QTI vs. TLSI, SMTI, EMBC, KRMD, and INFU

How does QT Imaging compare to TriSalus Life Sciences?

Summary

How does QT Imaging compare to Sanara MedTech?

Summary

How does QT Imaging compare to Embecta?

Summary

How does QT Imaging compare to KORU Medical Systems?

Summary

How does QT Imaging compare to InfuSystem?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTI vs. The Competition

QT Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

QT Imaging (QTI) Competitors

QTI vs. TLSI, SMTI, EMBC, KRMD, and INFU

How does QT Imaging compare to TriSalus Life Sciences?

Do analysts recommend QTI or TLSI?

Do insiders & institutionals believe in QTI or TLSI?

Which has preferable earnings and valuation, QTI or TLSI?

Does the media favor QTI or TLSI?

Which has more risk & volatility, QTI or TLSI?

Is QTI or TLSI more profitable?

Summary

How does QT Imaging compare to Sanara MedTech?

Which has more volatility and risk, SMTI or QTI?

Is SMTI or QTI more profitable?

Do analysts prefer SMTI or QTI?

Which has better valuation and earnings, SMTI or QTI?

Does the media refer more to SMTI or QTI?

Do insiders & institutionals believe in SMTI or QTI?

Summary

How does QT Imaging compare to Embecta?

Which has better earnings and valuation, EMBC or QTI?

Does the media prefer EMBC or QTI?

Which has more risk & volatility, EMBC or QTI?

Do analysts prefer EMBC or QTI?

Do institutionals and insiders believe in EMBC or QTI?

Is EMBC or QTI more profitable?

Summary

How does QT Imaging compare to KORU Medical Systems?

Does the media prefer QTI or KRMD?

Do insiders & institutionals believe in QTI or KRMD?

Which has more volatility and risk, QTI or KRMD?

Is QTI or KRMD more profitable?

Which has higher valuation and earnings, QTI or KRMD?

Do analysts rate QTI or KRMD?

Summary

How does QT Imaging compare to InfuSystem?

Is QTI or INFU more profitable?

Which has preferable valuation and earnings, QTI or INFU?

Do analysts prefer QTI or INFU?

Does the media prefer QTI or INFU?

Which has more risk & volatility, QTI or INFU?

Do institutionals & insiders believe in QTI or INFU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTI vs. The Competition

QT Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools